BioSpace News Archive

Bolden Therapeutics, Inc. today announced their upcoming presentation at the BIO International Convention during Jun 5th -8th in Boston, MA.

McKesson Corporation announced that it has commenced an offer to purchase for cash any and all of its outstanding 3.796% Notes due 2024.

Novir has announced the launch of their refreshed brand, dedicated to showcasing the evolution Novir has taken from a COVID-19 testing and vaccination provider to a more comprehensive healthcare solution committed to advancing healthcare from sick-care to pre-care by offering affordable, accessible, and reliable screening solutions to anyone, anywhere, anytime.

Dr. Alan K. Jacobs joins Satellos as CMO on June 7th, 2023

An artificial intelligence computer program can read physicians’ notes to accurately estimate patients’ risk of death, length of hospital stay, and other factors important to care.

hC Bioscience announced its tRNA-based therapy demonstrated proof-of-concept in an in vivo model of metastatic colorectal cancer with 75% tumor growth inhibition.

Inventiva announced that five abstracts have been selected for poster presentation at the upcoming International Liver Congress™ 2023 hosted by the European Association for the Study of the Liver on June 21-24, 2023 in Vienna, Austria.

89bio, Inc. today announced that pegozafermin data in nonalcoholic steatohepatitis (NASH) will be featured in a late-breaker oral presentation during the European Association for the Study of the Liver (EASL) Congress 2023 to be held June 21-24, 2023 in Vienna.

DTx Pharma today announced that the United States Food and Drug Administration (FDA) has granted Orphan Drug Designation to DTx-1252.

ENDRA Life Sciences Inc. (NASDAQ: NDRA), a pioneer of Thermo Acoustic Enhanced UltraSound (TAEUS ® ), today announced the acceptance of a poster titled “Thermoacoustic assessment of fatty liver disease - an early clinical feasibility study” for presentation at the International Liver Congress ™ 2023 hosted by the European Association for the Study of the Liver (EASL), taking place June 21-24 in Vienna, Austria.